메뉴 건너뛰기




Volumn 13, Issue 1, 2013, Pages

Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreases the adverse effects of the treatment: A prospective, randomized, double-blind, placebo-controlled study

Author keywords

Adverse effects; Functional dyspepsia; Furazolidone; Helicobacter pylori eradication; Peptic ulcer; Probiotic; Tetracycline; Treatment efficacy

Indexed keywords

FURAZOLIDONE; LANSOPRAZOLE; PLACEBO; PROBIOTIC AGENT; TETRACYCLINE;

EID: 84875336094     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-13-56     Document Type: Article
Times cited : (58)

References (51)
  • 1
    • 23644431875 scopus 로고    scopus 로고
    • [Second Brazilian Consensus Conference on Helicobacter pylori infection]
    • Coelho LG, Zaterka S. [Second Brazilian Consensus Conference on Helicobacter pylori infection]. Arq Gastroenterol 2005, 42:128-132.
    • (2005) Arq Gastroenterol , vol.42 , pp. 128-132
    • Coelho, L.G.1    Zaterka, S.2
  • 2
    • 34547619783 scopus 로고    scopus 로고
    • American College of Gastroenterology guideline on the management of Helicobacter pylori infection
    • 10.1111/j.1572-0241.2007.01393.x, 17608775
    • Chey WD, Wong BC. American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007, 102:1808-1825. 10.1111/j.1572-0241.2007.01393.x, 17608775.
    • (2007) Am J Gastroenterol , vol.102 , pp. 1808-1825
    • Chey, W.D.1    Wong, B.C.2
  • 4
    • 44649181072 scopus 로고    scopus 로고
    • Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer
    • 10.1111/j.1572-0241.2008.01819.x, 18341483
    • Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008, 103:510-514. 10.1111/j.1572-0241.2008.01819.x, 18341483.
    • (2008) Am J Gastroenterol , vol.103 , pp. 510-514
    • Talley, N.J.1    Fock, K.M.2    Moayyedi, P.3
  • 5
    • 84873110000 scopus 로고    scopus 로고
    • Helicobacter pylori Eradication Therapy: Current Availabilities
    • 3414051, 22900197
    • Gasparetto M, Pescarin M, Guariso G. Helicobacter pylori Eradication Therapy: Current Availabilities. ISRN Gastroenterol 2012, 2012:186734. 3414051, 22900197.
    • (2012) ISRN Gastroenterol , vol.2012 , pp. 186734
    • Gasparetto, M.1    Pescarin, M.2    Guariso, G.3
  • 6
    • 0027512416 scopus 로고
    • Patient factors affecting Helicobacter pylori eradication with triple therapy
    • Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993, 88:505-509.
    • (1993) Am J Gastroenterol , vol.88 , pp. 505-509
    • Cutler, A.F.1    Schubert, T.T.2
  • 7
    • 77955023115 scopus 로고    scopus 로고
    • Efficacy of 1-week proton pump inhibitor triple therapy as first-line Helicobacter pylori eradication regime in Asian patients: is it still effective 10 years on?
    • Qua CS, Manikam J, Goh KL. Efficacy of 1-week proton pump inhibitor triple therapy as first-line Helicobacter pylori eradication regime in Asian patients: is it still effective 10 years on?. J Dig Dis 2010, 11:244-248.
    • (2010) J Dig Dis , vol.11 , pp. 244-248
    • Qua, C.S.1    Manikam, J.2    Goh, K.L.3
  • 8
    • 0027436439 scopus 로고
    • Adverse effects of macrolide antibacterials
    • 10.2165/00002018-199309050-00004, 8280403
    • Periti P, Mazzei T, Mini E, Novelli A. Adverse effects of macrolide antibacterials. Drug Saf 1993, 9:346-364. 10.2165/00002018-199309050-00004, 8280403.
    • (1993) Drug Saf , vol.9 , pp. 346-364
    • Periti, P.1    Mazzei, T.2    Mini, E.3    Novelli, A.4
  • 9
    • 34447508333 scopus 로고    scopus 로고
    • Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy
    • 10.1093/jac/dkm111, 17449881
    • Salvo F, Polimeni G, Moretti U, Conforti A, Leone R, Leoni O, Motola D, Dusi G, Caputi AP. Adverse drug reactions related to amoxicillin alone and in association with clavulanic acid: data from spontaneous reporting in Italy. J Antimicrob Chemother 2007, 60:121-126. 10.1093/jac/dkm111, 17449881.
    • (2007) J Antimicrob Chemother , vol.60 , pp. 121-126
    • Salvo, F.1    Polimeni, G.2    Moretti, U.3    Conforti, A.4    Leone, R.5    Leoni, O.6    Motola, D.7    Dusi, G.8    Caputi, A.P.9
  • 11
    • 33846200694 scopus 로고    scopus 로고
    • Factors related to Helicobacter pylori prevalence in an adult population in Brazil
    • Zaterka S, Eisig JN, Chinzon D, Rothstein W. Factors related to Helicobacter pylori prevalence in an adult population in Brazil. Helicobacter 2007, 12:82-88.
    • (2007) Helicobacter , vol.12 , pp. 82-88
    • Zaterka, S.1    Eisig, J.N.2    Chinzon, D.3    Rothstein, W.4
  • 13
    • 78650101372 scopus 로고    scopus 로고
    • Seroprevalence of Helicobacter pylori infection among children of low socioeconomic level in Sao Paulo
    • 10.1590/S1516-31802010000400002, 21120427
    • Miranda AC, Machado RS, Silva EM, Kawakami E. Seroprevalence of Helicobacter pylori infection among children of low socioeconomic level in Sao Paulo. Sao Paulo Med J 2010, 128:187-191. 10.1590/S1516-31802010000400002, 21120427.
    • (2010) Sao Paulo Med J , vol.128 , pp. 187-191
    • Miranda, A.C.1    Machado, R.S.2    Silva, E.M.3    Kawakami, E.4
  • 14
    • 77954826590 scopus 로고    scopus 로고
    • Seroprevalence and potential risk factors for Helicobacter pylori infection in Brazilian children
    • 10.1111/j.1523-5378.2010.00766.x, 2913100, 20633188
    • Dattoli VC, Veiga RV, da Cunha SS, Pontes-de-Carvalho LC, Barreto ML, Alcantara-Neves NM. Seroprevalence and potential risk factors for Helicobacter pylori infection in Brazilian children. Helicobacter 2010, 15:273-278. 10.1111/j.1523-5378.2010.00766.x, 2913100, 20633188.
    • (2010) Helicobacter , vol.15 , pp. 273-278
    • Dattoli, V.C.1    Veiga, R.V.2    da Cunha, S.S.3    Pontes-de-Carvalho, L.C.4    Barreto, M.L.5    Alcantara-Neves, N.M.6
  • 15
    • 31144433306 scopus 로고    scopus 로고
    • Helicobacter pylori infection in adults from a poor urban community in northeastern Brazil: demographic, lifestyle and environmental factors
    • 10.1590/S1413-86702005000500008, 16410892
    • Rodrigues MN, Queiroz DM, Rodrigues RT, Rocha AM, Braga Neto MB, Braga LL. Helicobacter pylori infection in adults from a poor urban community in northeastern Brazil: demographic, lifestyle and environmental factors. Braz J Infect Dis 2005, 9:405-410. 10.1590/S1413-86702005000500008, 16410892.
    • (2005) Braz J Infect Dis , vol.9 , pp. 405-410
    • Rodrigues, M.N.1    Queiroz, D.M.2    Rodrigues, R.T.3    Rocha, A.M.4    Braga Neto, M.B.5    Braga, L.L.6
  • 16
    • 28344446701 scopus 로고    scopus 로고
    • Prevalence of Helicobacter pylori infection in Fortaleza, Northeastern Brazil
    • 10.1590/S0034-89102005000500022, 16254664
    • Rodrigues MN, Queiroz DM, Rodrigues RT, Rocha AM, Luz CR, Braga LL. Prevalence of Helicobacter pylori infection in Fortaleza, Northeastern Brazil. Rev Saude Publica 2005, 39:847-849. 10.1590/S0034-89102005000500022, 16254664.
    • (2005) Rev Saude Publica , vol.39 , pp. 847-849
    • Rodrigues, M.N.1    Queiroz, D.M.2    Rodrigues, R.T.3    Rocha, A.M.4    Luz, C.R.5    Braga, L.L.6
  • 17
    • 19244365859 scopus 로고    scopus 로고
    • Prevalence and risk factors associated with Helicobacter pylori infection in native populations from Brazilian Western Amazon
    • 10.1016/S0035-9203(03)90063-0, 15259462
    • Almeida Cunha RP, Alves FP, Rocha AM, Rocha GA, Camargo LM, Nogueira PO, Camargo EP, Queiroz DM. Prevalence and risk factors associated with Helicobacter pylori infection in native populations from Brazilian Western Amazon. Trans R Soc Trop Med Hyg 2003, 97:382-386. 10.1016/S0035-9203(03)90063-0, 15259462.
    • (2003) Trans R Soc Trop Med Hyg , vol.97 , pp. 382-386
    • Almeida Cunha, R.P.1    Alves, F.P.2    Rocha, A.M.3    Rocha, G.A.4    Camargo, L.M.5    Nogueira, P.O.6    Camargo, E.P.7    Queiroz, D.M.8
  • 19
    • 80052906813 scopus 로고    scopus 로고
    • Primary antibiotic resistance of Helicobacter pylori strains isolated from Portuguese children: a prospective multicentre study over a 10 year period
    • 10.1093/jac/dkr293, 21764826
    • Oleastro M, Cabral J, Ramalho PM, Lemos PS, Paixao E, Benoliel J, Santos A, Lopes AI. Primary antibiotic resistance of Helicobacter pylori strains isolated from Portuguese children: a prospective multicentre study over a 10 year period. J Antimicrob Chemother 2011, 66:2308-2311. 10.1093/jac/dkr293, 21764826.
    • (2011) J Antimicrob Chemother , vol.66 , pp. 2308-2311
    • Oleastro, M.1    Cabral, J.2    Ramalho, P.M.3    Lemos, P.S.4    Paixao, E.5    Benoliel, J.6    Santos, A.7    Lopes, A.I.8
  • 20
    • 79956085805 scopus 로고    scopus 로고
    • High Helicobacter pylori resistance to metronidazole but zero or low resistance to clarithromycin, levofloxacin, and other antibiotics in Malaysia
    • 10.1111/j.1523-5378.2011.00841.x, 21585611
    • Goh KL, Navaratnam P. High Helicobacter pylori resistance to metronidazole but zero or low resistance to clarithromycin, levofloxacin, and other antibiotics in Malaysia. Helicobacter 2011, 16:241-245. 10.1111/j.1523-5378.2011.00841.x, 21585611.
    • (2011) Helicobacter , vol.16 , pp. 241-245
    • Goh, K.L.1    Navaratnam, P.2
  • 22
    • 0034583821 scopus 로고    scopus 로고
    • Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil
    • 10.1046/j.1523-5378.2000.00011.x, 10849055
    • Mendonca S, Ecclissato C, Sartori MS, Godoy AP, Guerzoni RA, Degger M, Pedrazzoli J. Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil. Helicobacter 2000, 5:79-83. 10.1046/j.1523-5378.2000.00011.x, 10849055.
    • (2000) Helicobacter , vol.5 , pp. 79-83
    • Mendonca, S.1    Ecclissato, C.2    Sartori, M.S.3    Godoy, A.P.4    Guerzoni, R.A.5    Degger, M.6    Pedrazzoli, J.7
  • 23
    • 2442713982 scopus 로고    scopus 로고
    • Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates
    • 10.1186/1471-230X-3-20, 194586, 12911839
    • Godoy AP, Ribeiro ML, Benvengo YH, Vitiello L, Miranda Mde C, Mendonca S, Pedrazzoli J. Analysis of antimicrobial susceptibility and virulence factors in Helicobacter pylori clinical isolates. BMC Gastroenterol 2003, 3:20. 10.1186/1471-230X-3-20, 194586, 12911839.
    • (2003) BMC Gastroenterol , vol.3 , pp. 20
    • Godoy, A.P.1    Ribeiro, M.L.2    Benvengo, Y.H.3    Vitiello, L.4    Miranda Mde, C.5    Mendonca, S.6    Pedrazzoli, J.7
  • 25
    • 0036725793 scopus 로고    scopus 로고
    • Omeprazole, furazolidone, and tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease
    • Silva FM, Eisig JN, Chehter EZ, Silva JJ, Laudanna AA. Omeprazole, furazolidone, and tetracycline: an eradication treatment for resistant H. pylori in Brazilian patients with peptic ulcer disease. Rev Hosp Clin Fac Med Sao Paulo 2002, 57:205-208.
    • (2002) Rev Hosp Clin Fac Med Sao Paulo , vol.57 , pp. 205-208
    • Silva, F.M.1    Eisig, J.N.2    Chehter, E.Z.3    Silva, J.J.4    Laudanna, A.A.5
  • 26
    • 0025611647 scopus 로고
    • Drug therapy for Helicobacter pylori infection: problems and pitfalls
    • Glupczynski Y, Burette A. Drug therapy for Helicobacter pylori infection: problems and pitfalls. Am J Gastroenterol 1990, 85:1545-1551.
    • (1990) Am J Gastroenterol , vol.85 , pp. 1545-1551
    • Glupczynski, Y.1    Burette, A.2
  • 27
    • 0036169715 scopus 로고    scopus 로고
    • High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study
    • 10.1046/j.1365-2036.2002.01173.x, 11860415
    • Peitz U, Sulliga M, Wolle K, Leodolter A, Von Arnim U, Kahl S, Stolte M, Borsch G, Labenz J, Malfertheiner P. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study. Aliment Pharmacol Ther 2002, 16:315-324. 10.1046/j.1365-2036.2002.01173.x, 11860415.
    • (2002) Aliment Pharmacol Ther , vol.16 , pp. 315-324
    • Peitz, U.1    Sulliga, M.2    Wolle, K.3    Leodolter, A.4    Von Arnim, U.5    Kahl, S.6    Stolte, M.7    Borsch, G.8    Labenz, J.9    Malfertheiner, P.10
  • 28
    • 80054701283 scopus 로고    scopus 로고
    • Treatment of Helicobacter pylori
    • 10.1097/MOG.0b013e32834bb818, 21946029
    • Selgrad M, Malfertheiner P. Treatment of Helicobacter pylori. Curr Opin Gastroenterol 2011, 27:565-570. 10.1097/MOG.0b013e32834bb818, 21946029.
    • (2011) Curr Opin Gastroenterol , vol.27 , pp. 565-570
    • Selgrad, M.1    Malfertheiner, P.2
  • 31
    • 0035129632 scopus 로고    scopus 로고
    • The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy
    • 10.1046/j.1365-2036.2001.00923.x, 11148433
    • Armuzzi A, Cremonini F, Bartolozzi F, Canducci F, Candelli M, Ojetti V, Cammarota G, Anti M, De Lorenzo A, Pola P. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment Pharmacol Ther 2001, 15:163-169. 10.1046/j.1365-2036.2001.00923.x, 11148433.
    • (2001) Aliment Pharmacol Ther , vol.15 , pp. 163-169
    • Armuzzi, A.1    Cremonini, F.2    Bartolozzi, F.3    Canducci, F.4    Candelli, M.5    Ojetti, V.6    Cammarota, G.7    Anti, M.8    De Lorenzo, A.9    Pola, P.10
  • 32
    • 0036840803 scopus 로고    scopus 로고
    • Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study
    • 10.1111/j.1572-0241.2002.07063.x, 12425542
    • Cremonini F, Di Caro S, Covino M, Armuzzi A, Gabrielli M, Santarelli L, Nista EC, Cammarota G, Gasbarrini G, Gasbarrini A. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am J Gastroenterol 2002, 97:2744-2749. 10.1111/j.1572-0241.2002.07063.x, 12425542.
    • (2002) Am J Gastroenterol , vol.97 , pp. 2744-2749
    • Cremonini, F.1    Di Caro, S.2    Covino, M.3    Armuzzi, A.4    Gabrielli, M.5    Santarelli, L.6    Nista, E.C.7    Cammarota, G.8    Gasbarrini, G.9    Gasbarrini, A.10
  • 33
    • 79960816726 scopus 로고    scopus 로고
    • Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori
    • 10.1345/aph.1Q104, 21693698
    • Wilhelm SM, Johnson JL, Kale-Pradhan PB. Treating bugs with bugs: the role of probiotics as adjunctive therapy for Helicobacter pylori. Ann Pharmacother 2011, 45:960-966. 10.1345/aph.1Q104, 21693698.
    • (2011) Ann Pharmacother , vol.45 , pp. 960-966
    • Wilhelm, S.M.1    Johnson, J.L.2    Kale-Pradhan, P.B.3
  • 35
    • 84863561127 scopus 로고    scopus 로고
    • Probiotics-containing yogurts suppress Helicobacter pylori load and modify immune response and intestinal microbiota in the Helicobacter pylori-infected children
    • 10.1111/j.1523-5378.2012.00941.x, 22759330
    • Yang YJ, Sheu BS. Probiotics-containing yogurts suppress Helicobacter pylori load and modify immune response and intestinal microbiota in the Helicobacter pylori-infected children. Helicobacter 2012, 17:297-304. 10.1111/j.1523-5378.2012.00941.x, 22759330.
    • (2012) Helicobacter , vol.17 , pp. 297-304
    • Yang, Y.J.1    Sheu, B.S.2
  • 36
    • 58149140378 scopus 로고    scopus 로고
    • Lactobacilli inhibit interleukin-8 production induced by Helicobacter pylori lipopolysaccharide-activated Toll-like receptor 4
    • 10.3748/wjg.14.5090, 2742940, 18763295
    • Zhou C, Ma FZ, Deng XJ, Yuan H, Ma HS. Lactobacilli inhibit interleukin-8 production induced by Helicobacter pylori lipopolysaccharide-activated Toll-like receptor 4. World J Gastroenterol 2008, 14:5090-5095. 10.3748/wjg.14.5090, 2742940, 18763295.
    • (2008) World J Gastroenterol , vol.14 , pp. 5090-5095
    • Zhou, C.1    Ma, F.Z.2    Deng, X.J.3    Yuan, H.4    Ma, H.S.5
  • 37
    • 84867695562 scopus 로고    scopus 로고
    • Eradication of Helicobacter pylori infection by the probiotic strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32
    • 10.1111/j.1523-5378.2012.00992.x, 23067294
    • Hsieh PS, Tsai YC, Chen YC, Teh SF, Ou CM, King VA. Eradication of Helicobacter pylori infection by the probiotic strains Lactobacillus johnsonii MH-68 and L. salivarius ssp. salicinius AP-32. Helicobacter 2012, 17:466-477. 10.1111/j.1523-5378.2012.00992.x, 23067294.
    • (2012) Helicobacter , vol.17 , pp. 466-477
    • Hsieh, P.S.1    Tsai, Y.C.2    Chen, Y.C.3    Teh, S.F.4    Ou, C.M.5    King, V.A.6
  • 38
    • 80053913276 scopus 로고    scopus 로고
    • Alternative therapies for Helicobacter pylori: probiotics and phytomedicine
    • 10.1111/j.1574-695X.2011.00865.x, 22077218
    • Vítor JM, Vale FF. Alternative therapies for Helicobacter pylori: probiotics and phytomedicine. FEMS Immunol Med Microbiol 2011, 63:153-164. 10.1111/j.1574-695X.2011.00865.x, 22077218.
    • (2011) FEMS Immunol Med Microbiol , vol.63 , pp. 153-164
    • Vítor, J.M.1    Vale, F.F.2
  • 39
    • 0034536409 scopus 로고    scopus 로고
    • A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates
    • 10.1046/j.1365-2036.2000.00885.x, 11121911
    • Canducci F, Armuzzi A, Cremonini F, Cammarota G, Bartolozzi F, Pola P, Gasbarrini G, Gasbarrini A. A lyophilized and inactivated culture of Lactobacillus acidophilus increases Helicobacter pylori eradication rates. Aliment Pharmacol Ther 2000, 14:1625-1629. 10.1046/j.1365-2036.2000.00885.x, 11121911.
    • (2000) Aliment Pharmacol Ther , vol.14 , pp. 1625-1629
    • Canducci, F.1    Armuzzi, A.2    Cremonini, F.3    Cammarota, G.4    Bartolozzi, F.5    Pola, P.6    Gasbarrini, G.7    Gasbarrini, A.8
  • 40
    • 78449305654 scopus 로고    scopus 로고
    • Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment
    • 10.1111/j.1365-2036.2010.04457.x, 21039671
    • Szajewska H, Horvath A, Piwowarczyk A. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther 2010, 32:1069-1079. 10.1111/j.1365-2036.2010.04457.x, 21039671.
    • (2010) Aliment Pharmacol Ther , vol.32 , pp. 1069-1079
    • Szajewska, H.1    Horvath, A.2    Piwowarczyk, A.3
  • 41
    • 70349132036 scopus 로고    scopus 로고
    • Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication
    • Zou J, Dong J, Yu X. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter 2009, 14:97-107.
    • (2009) Helicobacter , vol.14 , pp. 97-107
    • Zou, J.1    Dong, J.2    Yu, X.3
  • 43
    • 84871592978 scopus 로고    scopus 로고
    • Meta-Analysis of the Efficacy and Safety of Lactobacillus-containing and Bifidobacterium-containing Probiotic Compound Preparation in Helicobacter pylori Eradication Therapy
    • 10.1097/MCG.0b013e318266f6cf, 23090045
    • Wang ZH, Gao QY, Fang JY. Meta-Analysis of the Efficacy and Safety of Lactobacillus-containing and Bifidobacterium-containing Probiotic Compound Preparation in Helicobacter pylori Eradication Therapy. J Clin Gastroenterol 2013, 47:25-32. 10.1097/MCG.0b013e318266f6cf, 23090045.
    • (2013) J Clin Gastroenterol , vol.47 , pp. 25-32
    • Wang, Z.H.1    Gao, Q.Y.2    Fang, J.Y.3
  • 44
    • 84862297498 scopus 로고    scopus 로고
    • Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy
    • 3368352, 22690211
    • Ojetti V, Bruno G, Ainora ME, Gigante G, Rizzo G, Roccarina D, Gasbarrini A. Impact of Lactobacillus reuteri Supplementation on Anti-Helicobacter pylori Levofloxacin-Based Second-Line Therapy. Gastroenterol Res Pract 2012, 2012:740381. 3368352, 22690211.
    • (2012) Gastroenterol Res Pract , vol.2012 , pp. 740381
    • Ojetti, V.1    Bruno, G.2    Ainora, M.E.3    Gigante, G.4    Rizzo, G.5    Roccarina, D.6    Gasbarrini, A.7
  • 45
    • 84873930517 scopus 로고    scopus 로고
    • Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection
    • 10.3748/wjg.v18.i43.6302, 3501780, 23180952
    • Du YQ, Su T, Fan JG, Lu YX, Zheng P, Li XH, Guo CY, Xu P, Gong YF, Li ZS. Adjuvant probiotics improve the eradication effect of triple therapy for Helicobacter pylori infection. World J Gastroenterol 2012, 18:6302-6307. 10.3748/wjg.v18.i43.6302, 3501780, 23180952.
    • (2012) World J Gastroenterol , vol.18 , pp. 6302-6307
    • Du, Y.Q.1    Su, T.2    Fan, J.G.3    Lu, Y.X.4    Zheng, P.5    Li, X.H.6    Guo, C.Y.7    Xu, P.8    Gong, Y.F.9    Li, Z.S.10
  • 46
    • 84863594703 scopus 로고    scopus 로고
    • Helicobacter pylori infection in clinical practice: probiotics and a combination of probiotics + lactoferrin improve compliance, but not eradication, in sequential therapy
    • 10.1111/j.1523-5378.2012.00944.x, 22759324
    • Manfredi M, Bizzarri B, Sacchero RI, Maccari S, Calabrese L, Fabbian F, De'Angelis GL. Helicobacter pylori infection in clinical practice: probiotics and a combination of probiotics + lactoferrin improve compliance, but not eradication, in sequential therapy. Helicobacter 2012, 17:254-263. 10.1111/j.1523-5378.2012.00944.x, 22759324.
    • (2012) Helicobacter , vol.17 , pp. 254-263
    • Manfredi, M.1    Bizzarri, B.2    Sacchero, R.I.3    Maccari, S.4    Calabrese, L.5    Fabbian, F.6    De'Angelis, G.L.7
  • 47
    • 84868249208 scopus 로고    scopus 로고
    • Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone
    • 10.1186/1824-7288-38-63, 3502296, 23114016
    • Tolone S, Pellino V, Vitaliti G, Lanzafame A, Tolone C. Evaluation of Helicobacter Pylori eradication in pediatric patients by triple therapy plus lactoferrin and probiotics compared to triple therapy alone. Ital J Pediatr 2012, 38:63. 10.1186/1824-7288-38-63, 3502296, 23114016.
    • (2012) Ital J Pediatr , vol.38 , pp. 63
    • Tolone, S.1    Pellino, V.2    Vitaliti, G.3    Lanzafame, A.4    Tolone, C.5
  • 48
    • 0037325483 scopus 로고    scopus 로고
    • Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects
    • 10.1046/j.1365-2036.2003.01452.x, 12562457
    • Cats A, Kuipers EJ, Bosschaert MA, Pot RG, Vandenbroucke-Grauls CM, Kusters JG. Effect of frequent consumption of a Lactobacillus casei-containing milk drink in Helicobacter pylori-colonized subjects. Aliment Pharmacol Ther 2003, 17:429-435. 10.1046/j.1365-2036.2003.01452.x, 12562457.
    • (2003) Aliment Pharmacol Ther , vol.17 , pp. 429-435
    • Cats, A.1    Kuipers, E.J.2    Bosschaert, M.A.3    Pot, R.G.4    Vandenbroucke-Grauls, C.M.5    Kusters, J.G.6
  • 49
    • 78650344748 scopus 로고    scopus 로고
    • Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection
    • Yoon H, Kim N, Kim JY, Park SY, Park JH, Jung HC, Song IS. Effects of multistrain probiotic-containing yogurt on second-line triple therapy for Helicobacter pylori infection. J Gastroenterol Hepatol 2011, 26:44-48.
    • (2011) J Gastroenterol Hepatol , vol.26 , pp. 44-48
    • Yoon, H.1    Kim, N.2    Kim, J.Y.3    Park, S.Y.4    Park, J.H.5    Jung, H.C.6    Song, I.S.7
  • 50
    • 69449097367 scopus 로고    scopus 로고
    • Helicobacter pylori infection in pediatrics
    • Kindermann A, Lopes AI. Helicobacter pylori infection in pediatrics. Helicobacter 2009, 14(Suppl 1):52-57.
    • (2009) Helicobacter , vol.14 , Issue.SUPPL. 1 , pp. 52-57
    • Kindermann, A.1    Lopes, A.I.2
  • 51
    • 79956019241 scopus 로고    scopus 로고
    • Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone
    • 10.1007/s10096-010-1119-4, 21207091
    • Medeiros JA, Goncalves TM, Boyanova L, Pereira MI, de Carvalho JN, Pereira AM, Cabrita AM. Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone. Eur J Clin Microbiol Infect Dis 2011, 30:555-559. 10.1007/s10096-010-1119-4, 21207091.
    • (2011) Eur J Clin Microbiol Infect Dis , vol.30 , pp. 555-559
    • Medeiros, J.A.1    Goncalves, T.M.2    Boyanova, L.3    Pereira, M.I.4    de Carvalho, J.N.5    Pereira, A.M.6    Cabrita, A.M.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.